Malignant pleural mesothelioma: Radiologic-pathologic correlation

被引:46
作者
Miller, BH
RosadodeChristenson, ML
Mason, AC
Fleming, MV
White, CC
Krasna, MJ
机构
[1] ARMED FORCES INST PATHOL,DEPT RADIOL PATHOL,WASHINGTON,DC 20306
[2] ARMED FORCES INST PATHOL,DEPT PULM & MEDIASTINAL PATHOL,WASHINGTON,DC 20306
[3] UNIFORMED SERV UNIV HLTH SCI,DEPT RADIOL & NUCL MED,BETHESDA,MD 20814
[4] UNIV MARYLAND,DEPT RADIOL,BALTIMORE,MD
[5] UNIV MARYLAND,DEPT SURG,DIV THORAC & CARDIOVASC SURG,BALTIMORE,MD
[6] ST PAULS HOSP,DEPT RADIOL,VANCOUVER,BC,CANADA
关键词
asbestos; mesothelioma; pleura; neoplasms;
D O I
10.1148/radiographics.16.3.8897628
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Malignant pleural mesothelioma (MPM) is a rare malignant neoplasm that typically affects individuals occupationally exposed to asbestos through a variety of industries. The patients experience an insidious onset of symptoms, including dyspnea, chest pain, cough, malaise, and weight loss, The pathologic diagnosis of MPM is difficult, and special stains or immunohistochemical or ultrastructural analysis may be required to differentiate MPM from metastatic adenocarcinoma, The tumor affects both the parietal and visceral pleural surfaces and progresses to encase the lung and invade the lung, mediastinum, and chest wall, Radiologically, MPM manifests as unilateral pleural effusion, pleural nodules, or pleural masses. Imaging studies are useful for diagnosis and staging in patients who are potential surgical candidates, Although a variety of multimodality therapies are available and radical surgical procedures have been developed, the prognosis remains dismal.
引用
收藏
页码:613 / 644
页数:32
相关论文
共 82 条
[1]  
ADAMS VI, 1986, CANCER, V58, P1540, DOI 10.1002/1097-0142(19861001)58:7<1540::AID-CNCR2820580727>3.0.CO
[2]  
2-5
[3]   CURRENT APPROACH TO MALIGNANT MESOTHELIOMA OF THE PLEURA [J].
AISNER, J .
CHEST, 1995, 107 (06) :S332-S344
[4]  
Allen K B, 1994, Chest Surg Clin N Am, V4, P113
[5]  
AMIN KM, 1995, AM J PATHOL, V146, P344
[6]  
Anderson H A, 1979, Ann N Y Acad Sci, V330, P387, DOI 10.1111/j.1749-6632.1979.tb18741.x
[7]   MALIGNANT MESOTHELIOMA [J].
ANTMAN, KH .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (04) :200-202
[8]   INTRAPLEURAL RECOMBINANT IL-2 IN PASSIVE IMMUNOTHERAPY FOR MALIGNANT PLEURAL EFFUSION [J].
ASTOUL, P ;
VIALLAT, JR ;
LAURENT, JC ;
BRANDELY, M ;
BOUTIN, C .
CHEST, 1993, 103 (01) :209-213
[9]  
BARIS YI, 1979, ANN NY ACAD SCI, V79, P423
[10]  
BOUTIN C, 1993, CANCER, V72, P389, DOI 10.1002/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO